Navigation Links
Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
Date:6/16/2013

, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements, including our expected liquidity position and timing of the receipt of certain milestone payments, and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "goal", "should", "would", "project", "plan", "predict", "intend", "target" and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, expected liquidity or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing governmental regulation, our ability to commercialize, manufacture and achieve market acceptance of any of our product candidates, for which we rely heavily on collaboration with third parties, and our ability to protect and enforce our intellectual property rights and to operate without infringing upon the proprietary rights of third parties. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we can
'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Hill-Rom Reports Fiscal Second Quarter Adjusted Earnings Per Share In Line With Expectations; Provides Third Quarter And Updated Full-Year Financial Outlook
2. Updated HHS Mandate Continues Attack on Religious Freedom
3. Hoggan Scientific Unveils Updated ergoFET Force Gauge for Improved Force Evaluation
4. Updated: LHA Life Sciences & Medical Technologies Virtual Conference
5. Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO
6. Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
7. NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 International Congress of Parkinsons Disease and Movement Disorders
8. New PrEP Trial Results Among Injecting Drug Users Underscore That PrEP Works When Taken Consistently
9. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
10. Lakeland Industries to Report Fiscal First Quarter Financial Results and Conduct Conference Call
11. Adamas Pharmaceuticals To Report Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia In Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 Cogentix Medical, Inc. (NASDAQ: ... urology market, will release financial results for the first quarter ... the market close on Monday, August 10, 2015. ... to discuss these results on Monday, August 10, 2015 at ... Kill , President and Chief Executive Officer, and Brett ...
(Date:7/29/2015)... Calif. , July 29, 2015  AcelRx ... pharmaceutical company focused on the development and commercialization ... and breakthrough pain, today announced that it will ... on Monday, Aug 3rd, 2015. AcelRx management will ... Eastern Time (1:30 p.m. Pacific Time) on Aug ...
(Date:7/29/2015)... MOUNTAIN VIEW, Calif. , July 29, 2015 /PRNewswire/ ... in the growth strategy of pharmaceutical firms in ... . The realization is that an effective working ... sales, pricing pressures and patent cliffs. Big pharma companies ... bolster returns. Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO ...
Breaking Medicine Technology:Cogentix Medical to Announce First Quarter Fiscal 2016 Results on August 10, 2015 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4
... Nov. 20 Smith & Nephew ( SNN, LSE: SN) ... technology development contract with the United States Department of Defense ... system intended to revolutionize the treatment of the limbs of ... Advanced Research Projects Agency (DARPA), the central research and development ...
... 19 In response to an ever-increasing number of ... involving 24 countries, was coordinated by INTERPOL and the ... to highlight the dangers of buying medicines online. , ... of arrests and the seizure of thousands of potentially ...
Cached Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2
(Date:7/29/2015)... ... 2015 , ... The New Foundation AZ recently started a massive ... cost the 501(c) organization nearly $1 million, will both update the facilities’ design and ... it down to the studs,” said Geraldine Leary, the New Foundation AZ chief executive ...
(Date:7/29/2015)... ... 29, 2015 , ... National non-profit World T.E.A.M. Sports announced ... employee benefits and asset management, has joined as presenting sponsor for the inaugural ... Charlotte, North Carolina on October 2-4, 2015. , Hosted at the U.S. ...
(Date:7/29/2015)... Indiana (PRWEB) , ... July 29, 2015 , ... Indiana ... It is also the home of Zerorez Indianapolis, which plans to expand across ... late 2013. “2015 is our second full year in business and we should double ...
(Date:7/29/2015)... Antonio, TX (PRWEB) , ... July 29, 2015 ... ... by a board-certified gastroenterologist, has launched a chewable version of its EndoMune Jr. ... to be a tasty, all-natural supplement that children can enjoy to maintain a ...
(Date:7/29/2015)... TN (PRWEB) , ... July 29, 2015 , ... ... Value-Added Solutions Group, which Breckheimer oversees. In her role, Powers is responsible for ... Upon making the announcement, Breckheimer commented, “Gina’s track record as an effective leader ...
Breaking Medicine News(10 mins):Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3
... stroke, irrespective of traditional vascular risk factors, according to ... partly heritable. However, the importance of genetic and environmental ... the Stroke Prevention Research Unit at the Radcliffe Infirmary, ... patients who had an ischaemic stroke or transient ischaemic ...
... shown that the chemical language with which neurons communicate ... developing nervous system. The findings suggest that modification of ... a wide range of brain disorders. ,In the ... of the journal Proceedings of the National Academy of ...
... Saha and collaborators have found that the genetically engineered ... sources could set the stage for a new, biobased ... chewing gum, toothpaste, mouthwash and other products. ... and even to some degree by the human body. ...
... Medical School Researchers are developing the first of the generation ... the hospital superbug MRSA that lives in the nose. ... by standard antibiotics because the bacteria have developed a resistance ... scheduled for testing in humans next year and may be ...
... medical park and a vaccine park in Chennai soon to ... for research into new vaccines, said Health Minister Anbumani Ramadoss. ... manufacture medical equipment for the country, the vaccine park will ... ,"The medical park will be built on 300 acres of ...
... A new study that takes a rare look at the ... settings shows that when older adults go to bed lonely, ... after waking the next morning. ,Elevated levels of ... other health problems when chronic -- actually cue the body ...
Cached Medicine News:Health News:Electrical Activity Alters Language Used By Nerve Cells 2Health News:Electrical Activity Alters Language Used By Nerve Cells 3Health News:India to set up medical and vaccine parks: Ramadoss 2Health News:Adults Who Go to Bed Lonely Get Stress Hormone Boost Next Morning 2Health News:Adults Who Go to Bed Lonely Get Stress Hormone Boost Next Morning 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: